Sangamo Therapeutics
SGMO
#10419
Rank
NZ$52.95 M
Marketcap
NZ$0.13
Share price
0.00%
Change (1 day)
-86.96%
Change (1 year)

Sangamo Therapeutics (SGMO) - Total liabilities

Total liabilities on the balance sheet as of March 2026 : NZ$0.13 Billion

According to Sangamo Therapeutics 's latest financial reports the company's total liabilities are NZ$0.13 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Sangamo Therapeutics - Total liabilities on balance sheet (from 2001 to 2026)

Total liabilities by year

Year Total liabilities Change
2025-12-31NZ$0.12 B-8.61%
2024-12-31NZ$0.13 B7.28%
2023-12-31NZ$0.13 B-69.07%
2022-12-31NZ$0.42 B-16.95%
2021-12-31NZ$0.50 B-17.02%
2020-12-31NZ$0.61 B101.1%
2019-12-31NZ$0.30 B-8.6%
2018-12-31NZ$0.33 B139.03%
2017-12-31NZ$0.13 B344.34%
2016-12-31NZ$31.32 M-13.55%
2015-12-31NZ$36.22 M-22.4%
2014-12-31NZ$46.68 M100.57%
2013-12-31NZ$23.27 M8.57%
2012-12-31NZ$21.43 M132.27%
2011-12-31NZ$9.23 M0.41%
2010-12-31NZ$9.19 M-57.36%
2009-12-31NZ$21.55 M0.45%
2008-12-31NZ$21.46 M39.57%
2007-12-31NZ$15.37 M53.11%
2006-12-31NZ$10.04 M-38.54%
2005-12-31NZ$16.34 M396.6%
2004-12-31NZ$3.29 M36.16%
2003-12-31NZ$2.41 M-36.15%
2002-12-31NZ$3.78 M-41.09%
2001-12-31NZ$6.42 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Johnson & Johnson
JNJ
NZ$206.78 B 151,582.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$143.91 B 105,467.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
NZ$18.71 B 13,624.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Dow
DOW
NZ$74.30 B 54,407.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
NZ$56.73 B 41,520.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$142.94 B 104,758.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
NZ$7.00 B 5,037.06%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
NZ$4.10 B 2,914.33%๐Ÿ‡บ๐Ÿ‡ธ USA